Immunohistochemical study of transforming growth factor-β1, matrix metalloproteinase-2,9, tissue inhibitors of metalloproteinase-1,2, and basement membrane components at pancreatic ducts in chronic pancreatitis

Pancreas

Volumn 17, Issue 4, 1998, Pages 412-418

  Ishihara, Takeshi ^a   Hayasaka, Akira ^a   Yamaguchi, Taketo ^a   Kondo, Fukuo ^a   Saisho, Hiromitsu ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basement membrane; Chronic pancreatitis; Laminin; MMP 2; TGF 1; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS DUCT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031737953     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199811000-00013     Document Type: Article

References (38)

1. Bordalo O, Goncalves D, Noronha M, Cristina ML, Salgadinho A. Newer concept for the pathogenesis of chronic alcoholic pancreatitis. Am J Gastroenterol 1977;68:278-85.
2. Klöppel G, Maillet B. The morphological basis for the evolution of acute pancreatitis into chronic pancreatitis. Virchows Arch A Pathol Anal Histopathol 1992;420:1-4.
3. DiMagno EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas: biology, pathobiology and disease. 2nd ed. New York: Raven, 1993:665-706.
4. Sarles H. Etiopathogenesis and definition of chronic pancreatitis. Dig Dis Sci 1986;31:91S-107S.
5. Ignotz RA, Massagué J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-45.
6. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-904.
7. Bramhall SR, Stamp GWH, Lemoine NR, Neoptolemos JP. The matrix metalloproteinases and their inhibitors in pancreatic cancer. In: Neoptolemos JP, Lemoine NR, eds. Pancreatic cancer. Oxford: Blackwell Science, 1996:68-91.
8. Bramhall SR. The matrix metalloproteinases and their inhibitors in pancreatic cancer. Int J Pancreatol 1997;21:1-12.
9. Ekblom P, Miettinen M, Rapola J, Foidart JM. Demonstration of laminin, a basement membrane glycoprotein, in routinely processed formalin-fixed human tissues. Histochemistry 1982;75: 301-7.
10. D'Errico A, Biagini G, Garbisa S, et al. Detection of extracellular matrix antigens (fibronectin, laminin, type IV collagen) in paraffin embedded sections by avidin-biotin-peroxidase complex labelling. Basic Appl Histochem 1986;30:325-32.
11. Satoh K, Ohtani H, Shimosegawa T, Koizumi M, Sawai T, Toyota T. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gastroenterology 1994;107:1488-95.
12. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
13. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, Jirtle R, Flanders K, Tsang MLS. Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am J Pathol 1995;147:1228-37.
14. Uscanga L, Kennedy RH, Stocker S, Grimaud JA, Sarles H. Immunolocalization of collagen types, laminin and fibronectin in the normal pancreas. Digestion 1984;30:158-64.
15. Kennedy RH, Bockman DE, Uscanga L, Choux R, Grimaud JA, Sarles H. Pancreatic extracellular matrix alterations in chronic pancreatitis. Pancreas 1987;2:61-72.
16. Shimoyama S, Gansauge F, Gansauge S, Oohara T, Beger HG. Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma, in comparison with normal pancreas. Int J Pancreatol 1995;18:227-34.
17. Imamura T, Manabe T, Ohshio G, et al. Immunohistochemical staining for type IV collagen and laminin in the stroma of human pancreatic cancer. Int J Pancreatol 1995;18:95-9.
18. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983;49:140-7.
19. Lee CS, Montebello J, Georgiou T, Rode J. Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis. Int J Exp Pathol 1994;75:79-83.
20. Haglund C, Nordling S, Roberts PJ, Ekblom P. Expression of laminin in pancreatic neoplasms and in chronic pancreatitis. Am J Surg Pathol 1984;8:669-76.
21. Bockman DE, Muller M, Büchler M, Friess H, Beger HG. Pathological changes in pancreatic ducts from patients with chronic pancreatitis. Int J Pancreatol 1997;21:119-26.
22. Arthur MJP. The metalloproteinases. In: Clément B, Guillouzo A, eds. Cellular and molecular aspects of cirrhosis. Montrouge: John Libbey Eurotext, 1992:235-43.
23. Cawston TE, Galloway WA, Mercer E, Murphy G, Reynolds JJ. Purification of rabbit bone inhibitor of collagenase. Biochem J 1981;195:59-165.
24. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72-and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266:13070-5.
25. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He C. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc Natl Acad Sci USA 1989;86:8207-11.
26. Gress TM, Müller PF, Lerch MM, et al. Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. Z Gastroenterol 1994;32:221-5.
27. Bramhall SR, Stamp GWH, Dunn J, Lemoine NR, Neoptolemos JP. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer 1996;73:972-8.
28. Imada K, Ito A, Sato T, et al. The requirement of cell surface binding of TIMP-2 for the activation of rabbit proMMP-2 by MT-MMP-1. Connect Tissue 1996;28:100.
29. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990;265:13933-8.
30. Menke A, Yamaguchi H, Gress TM, Adler G. Extracellular matrix is reduced by inhibition of transforming growth factor β1 in pancreatitis in the rat. Gastroenterology 1997;113:295-303.
31. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-5.
32. Gentry LE, Webb NR, Lim GJ, et al. Type I transforming growth factor β: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells. Mol Cell Biol 1987;7:3418-27.
33. Hollingsworth MA. Immunological properties of pancreatic ductal cells. In: Sirica AE. Longnecker DS. eds. Biliary and pancreatic ductal epithelia. New York: Marcel Dekker, 1997:409-41.
34. Iredale JP. Matrix turnover in fibrogenesis. Hepatogastroenterology 1996;43:56-71.
35. Yamanaka Y, Friess H, Büchler M, Beger HG, Gold LI, Korc M. Synthesis and expression of transforming growth factor β-1, β-2, and β-3 in the endocrine and exocrine pancreas. Diabetes 1993; 42:746-56.
36. Friess H, Yamanaka Y, Büchler M, et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-56.
37. Laethem JLV, Deviere J, Resibois A, et al. Localization of transforming growth factor β1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 1995;108:1873-81.
38. Slater SD, Williamson RCN, Foster CS. Expression of transforming growth factor-β1 in chronic pancreatitis. Digestion 1995;56: 237-41.